AEE
58
3
GIS
54
2
IFF
62
5
FSLR
60
-10
KIM
56
5
FTI
61
-2
CPB
37
2
HRL
38
3
EQT
51
-5
ALL
61
-2
O
35
4
F
58
2
GS
78
2
PG
43
2
KMB
33
2
PLD
33
3
DTE
42
4
ADM
47
2
NKE
36
6
DIS
72
2
AEE
58
3
GIS
54
2
IFF
62
5
FSLR
60
-10
KIM
56
5
FTI
61
-2
CPB
37
2
HRL
38
3
EQT
51
-5
ALL
61
-2
O
35
4
F
58
2
GS
78
2
PG
43
2
KMB
33
2
PLD
33
3
DTE
42
4
ADM
47
2
NKE
36
6
DIS
72
2
Financhill
Back

YieldMax AAPL Option Income Strategy ETF Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Sell
43

APLY
YieldMax AAPL Option Income Strategy ETF

Last Price:
$13.47
Seasonality Move:
-15.5%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$40.3200
Seasonality Move:
33.23%
Sell
43
YieldMax AAPL Option Income Strategy ETF (APLY) is a Sell

Is YieldMax AAPL Option Income Strategy ETF a Buy, Sell or Hold?

  • The current YieldMax AAPL Option Income Strategy ETF [APLY] share price is $13.45. The Score for APLY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • APLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

APLY Stock Price Chart

What is YieldMax AAPL Option Income Strategy ETF's stock price today?

  • The YieldMax AAPL Option Income Strategy ETF share price today is $13.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLY is experiencing slight buying pressure.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

APLY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 41.55 Sell
Chaikin Money Flow: 15789 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.48 - 13.92) Sell
Bollinger Bands (100): (13.25 - 13.87) Sell

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

APLY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.48 Sell
20-day SMA: 13.71 Sell
50-day SMA: 13.7 Sell
200-day SMA: 13.5 Sell
8-day EMA: 13.48 Sell
20-day EMA: 13.61 Sell
50-day EMA: 13.65 Sell
200-day EMA: 14.06 Sell

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

YieldMax AAPL Option Income Strategy ETF Earnings Growth & APLY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

YieldMax AAPL Option Income Strategy ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):